{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:47:55Z","timestamp":1790801275526,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12876-017-0591-z","type":"journal-article","created":{"date-parts":[[2017,3,11]],"date-time":"2017-03-11T03:47:59Z","timestamp":1489204079000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The utility of apoptosis inhibitor of macrophages as a possible diagnostic marker in patients with Crohn\u2019s disease"],"prefix":"10.1186","volume":"17","author":[{"given":"Yohei","family":"Ono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Kanmura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Morinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuto","family":"Kawabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiho","family":"Arima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumisato","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichirou","family":"Nasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiroh","family":"Tanoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Uto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohito","family":"Tsubouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Ido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,11]]},"reference":[{"key":"591_CR1","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1136\/gut.39.5.690","volume":"39","author":"S Shivananda","year":"1996","unstructured":"Shivananda S, Lennard J, Logan R, Fear N, Price A, Carpenter L, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? results of the European collaborative study on inflammatory bowel disease (EC-IBD). Gut. 1996;39:690\u20137.","journal-title":"Gut"},{"key":"591_CR2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","volume":"142","author":"NA Molodecky","year":"2012","unstructured":"Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chemoff G, Benchimol E, Panaccione R, Ghosh S, Barkema HW, Kaplan GG. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46\u201354.","journal-title":"Gastroenterology"},{"key":"591_CR3","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.immuni.2014.05.013","volume":"40","author":"C Huttenhower","year":"2014","unstructured":"Huttenhower C, Kostic AD, Xavier RJ. Inflammatory bowel disease as a model for translating the microbiome. Immunity. 2014;40:843\u201354.","journal-title":"Immunity"},{"key":"591_CR4","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1053\/gast.2000.20260","volume":"119","author":"T Kanai","year":"2000","unstructured":"Kanai T, Watanabe M, Okazawa A, Nakamaru K, Okamoto M, Naganuma M, Ishii H, Ikeda M, Kurimoto M, Hibi T. Interleukin 18 is a potent proliferative factor for intestinal mucosal lymphocytes in Crohn\u2019s disease. Gastroenterology. 2000;119:1514\u201323.","journal-title":"Gastroenterology"},{"key":"591_CR5","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/00042737-199709000-00013","volume":"9","author":"G Rogler","year":"1997","unstructured":"Rogler G, Andus T, Aschenbrenner E, Vogl D, Falk W, Sch\u00f6lmerich J, Gross V. Alterations of the phenotype of colonic macrophages in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1997;9:893\u20139.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"591_CR6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.smim.2006.09.002","volume":"19","author":"M Schenk","year":"2007","unstructured":"Schenk M, Mueller C. Adaptations of intestinal macrophages to an antigen-rich environment. Semin Immunol. 2007;19:84\u201393.","journal-title":"Semin Immunol"},{"key":"591_CR7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/gut.2010.224154","volume":"60","author":"C Mowat","year":"2011","unstructured":"Mowat C, Cole A, Windsor A, Ahmad T, Arnott I, Driscoll R, Mitton S, Orchard T, Rutter M, Younge L, Lees C, Ho GT, Satsangi J, Bloom S. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2011;60:571\u2013607.","journal-title":"Gut"},{"key":"591_CR8","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1053\/j.gastro.2007.09.001","volume":"133","author":"S Nikolaus","year":"2007","unstructured":"Nikolaus S, Schreiber S. Diagnostics of inflammatory bowel disease. Gastroenterology. 2007;133:1670\u201389.","journal-title":"Gastroenterology"},{"key":"591_CR9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4103\/1319-3767.105915","volume":"19","author":"MA Al-Mohammad","year":"2013","unstructured":"Al-Mohammad MA, Al-Ibrahim IA. Emerging inflammatory bowel disease in Saudi outpatients: a report of 693 cases. Saudi J Gastroenterol. 2013;19:16\u201322.","journal-title":"Saudi J Gastroenterol"},{"key":"591_CR10","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.crohns.2013.09.016","volume":"7","author":"V Annese","year":"2013","unstructured":"Annese V, Daperno M, Rutter MD, Amiot A, Bossuyt P, East J, Ferrante M, Gotz M, Katsanos KH, Kieblich R, Odras I, Repici A, Rosa B, Sebastian S, Kucharzik T, Eliakim R. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohn\u2019s Colitis. 2013;7:982\u20131018.","journal-title":"J Crohn\u2019s Colitis"},{"key":"591_CR11","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/S0140-6736(00)03488-7","volume":"356","author":"P Rutgeerts","year":"2000","unstructured":"Rutgeerts P, Vermeire S. Serological diagnosis of inflammatory bowel disease. Lancet. 2000;356:2117\u20138.","journal-title":"Lancet"},{"key":"591_CR12","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","volume":"340","author":"C Gabay","year":"1999","unstructured":"Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448\u201354.","journal-title":"N Engl J Med"},{"key":"591_CR13","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1136\/gut.27.7.809","volume":"27","author":"SH Saverymuttu","year":"1986","unstructured":"Saverymuttu SH, Hodgson HJ, Chadwick VS, Pepys MB. Differing acute phase responses in Crohn\u2019s disease and ulcerative colitis. Gut. 1986;27:809\u201313.","journal-title":"Gut"},{"key":"591_CR14","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/00004836-198612000-00011","volume":"8","author":"DB Sachar","year":"1986","unstructured":"Sachar DB, Smith H, Chan S, Cohen LB, Lichtiger S, Messer J. Erythrocytic sedimentation rate as a measure of clinical activity in inflammatory bowel disease. J Clin Gastroenterol. 1986;8:647\u201350.","journal-title":"J Clin Gastroenterol"},{"key":"591_CR15","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/gut.2004.043406","volume":"54","author":"F Costa","year":"2005","unstructured":"Costa F, Mumolo MG, Ceccarelli L, Bellini M, Romano MR, Sterpi C, Ricchiuti A, Marchi S, Bottai M. Calprotectin is a stronger marker of relapse in ulcerative colitis than in Crohn\u2019s disease. Gut. 2005;54:364\u20138.","journal-title":"Gut"},{"key":"591_CR16","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/gut.2005.069476","volume":"55","author":"S Vermeire","year":"2006","unstructured":"Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut. 2006;55:426\u201331.","journal-title":"Gut"},{"key":"591_CR17","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/00001574-200407000-00004","volume":"20","author":"SW Beaven","year":"2004","unstructured":"Beaven SW, Abreu MT. Biomarkers in inflammatory bowel disease. Curr Opin Gastroenterol. 2004;20:318\u201327.","journal-title":"Curr Opin Gastroenterol"},{"key":"591_CR18","first-page":"167","volume":"4","author":"WJ Sandborn","year":"2004","unstructured":"Sandborn WJ. Serologic markers in inflammatory bowel disease: state of the art. Rev Gastroenterol Disord. 2004;4:167\u201374.","journal-title":"Rev Gastroenterol Disord"},{"key":"591_CR19","first-page":"442","volume-title":"Kirsner\u2019s inflammatory bowel disease","author":"SR Targan","year":"2004","unstructured":"Targan SR, Karp LC. Serology and laboratory markers of disease activity. In: Sartor RB, Sandborn WJ, editors. Kirsner\u2019s inflammatory bowel disease. 6th ed. New York: Saunders; 2004. p. 442\u201352.","edition":"6"},{"key":"591_CR20","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/ibd.20854","volume":"15","author":"S Kanmura","year":"2009","unstructured":"Kanmura S, Uto H, Numata M, Hashimoto S, Moriuchi A, Fujita H, Oketani M, Ido A, Kodama M, Ohi H, Tsubouchi H. Human neutrophil peptides 1\u20133 are useful biomarkers in patients with active ulcerative colitis. Inflamm Bowel Dis. 2009;15:909\u201317.","journal-title":"Inflamm Bowel Dis"},{"key":"591_CR21","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/gut.42.6.788","volume":"42","author":"JF Quinton","year":"1998","unstructured":"Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, Charrier G, Targan SR, Colombel JF, Poulain D. Anti-Saccaromyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic antoantibodies in inflammatory bowel disease : prevalence and diagnostic role. Gut. 1998;42:788\u201391.","journal-title":"Gut"},{"key":"591_CR22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s005350300020","volume":"38","author":"T Hisabe","year":"2003","unstructured":"Hisabe T, Matsui T, Sakurai T, Murakami Y, Tanabe H, Matake H, Yao T, Kamachi S, Iwashita A. Anti-Saccharomyces cerevisiae antibodies in Japanese patients with inflammatory bowel disease: diagnostic accuracy and clinical value. J Gastroenterol. 2003;38:121\u20136.","journal-title":"J Gastroenterol"},{"key":"591_CR23","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.dld.2007.03.006","volume":"39","author":"BC Kim","year":"2007","unstructured":"Kim BC, Park S, Han J, Kim JH, Kim TI, Kim WH. Clinical significance of anti-Saccharomyces cerevisiae antibody (ASCA) in Korean patients with Crohn\u2019s disease and its relationship to the disease clinical course. Dig Liver Dis. 2007;39:610\u20136.","journal-title":"Dig Liver Dis"},{"key":"591_CR24","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00535-003-1117-8","volume":"38","author":"T Matsui","year":"2003","unstructured":"Matsui T, Yao T, Sakurai T, Yao K, Hirai F, Matake H, Tsuda S, Wada Y, Iwashita A, Kamachi S. Clinical features and pattern of indeterminate colitis: Crohn\u2019s disease with ulcerative colitis-like clinical presentation. J Gastroenterol. 2003;38:647\u201355.","journal-title":"J Gastroenterol"},{"key":"591_CR25","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1084\/jem.189.2.413","volume":"189","author":"T Miyazaki","year":"1999","unstructured":"Miyazaki T, Hirokami Y, Matsuhashi N, Takatsuka H, Nito M. Increased susceptibility of thymocytes to apoptosis in mice lacking AIM, a novel murine macrophage-derived soluble factor belonging to the scavenger receptor cysteine-rich domain superfamily. J Exp Med. 1999;189:413\u201322.","journal-title":"J Exp Med"},{"key":"591_CR26","doi-asserted-by":"crossref","first-page":"12072","DOI":"10.1073\/pnas.1101841108","volume":"108","author":"J Kurokawa","year":"2011","unstructured":"Kurokawa J, Nagano H, Ohara O, Kubota N, Kadowaki T, Arai S, Miyazaki T. Apoptosis inhibitor of macrophage (AIM) is required for obesity-associated recruitment of inflammatory macrophages into adipose tissue. Proc Natl Acad Sci U S A. 2011;108:12072\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"591_CR27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00281-013-0405-5","volume":"36","author":"S Arai","year":"2014","unstructured":"Arai S, Miyazaki T. Impacts of the apoptosis inhibitor of macrophage (AIM) on obesity-associated inflammatory disease. Smin Immnopathol. 2014;36:3\u201312.","journal-title":"Smin Immnopathol"},{"key":"591_CR28","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.bbrc.2012.05.018","volume":"422","author":"Y Iwamura","year":"2012","unstructured":"Iwamura Y, Mori M, Nakashima K, Mikami T, Murayama K, Arai S, Miyazaki T. Apoptosis inhibitor of macrophage (AIM) diminishes lipid droplet-coating proteins leading to lipolysis in adipocytes. Biochem Biophys Res Commun. 2012;422:476\u201381.","journal-title":"Biochem Biophys Res Commun"},{"key":"591_CR29","doi-asserted-by":"crossref","first-page":"22910","DOI":"10.1074\/jbc.M100324200","volume":"276","author":"I Haruta","year":"2001","unstructured":"Haruta I, Kato Y, Hashimoto E, Minjares C, Kennedy S, Uto H, Yamauchi K, Kobayashi M, Yusa S, Muller U, Hayashi N, Miyazaki T. Association of AIM, a novel apoptosis inhibitory factor, with hepatitis via supporting macrophage survival and enhancing phagocytotic function of macrophages. J Biol Chem. 2001;276:22910\u20134.","journal-title":"J Biol Chem"},{"key":"591_CR30","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1189\/jlb.0806510","volume":"81","author":"L Ziegler-Heitbrock","year":"2007","unstructured":"Ziegler-Heitbrock L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol. 2007;81:584\u201392.","journal-title":"J Leukoc Biol"},{"key":"591_CR31","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/j.1572-0241.2007.01714.x","volume":"103","author":"H Hanai","year":"2008","unstructured":"Hanai H, Iida T, Takeuchi K, Watanabe F, Yamada M, Kikuyama M. Adsorptive depletion of elevated proinflammatory CD14\u2009+\u2009CD16\u2009+\u2009DR++ monocytes in patients with inflammatory bowel disease. Am J Gastroenterol. 2008;103:1210\u20136.","journal-title":"Am J Gastroenterol"},{"key":"591_CR32","first-page":"2269","volume":"118","author":"N Kamada","year":"2008","unstructured":"Kamada N, Hisamatsu T, Okamoto S, Chinen H, Kobayashi T, Sato T, Sakuraba A, Kitazume MT, Sugita A, Koganei K, Akagawa KS, Hibi T. Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23\/IFN-gamma axis. J Clin Invest. 2008;118:2269\u201380.","journal-title":"J Clin Invest"},{"key":"591_CR33","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2249.2010.04177.x","volume":"161","author":"S Koch","year":"2010","unstructured":"Koch S, Kucharzik T, Heidemann J, Nusrat A, Luegering A. Investigating the role of proinflammatory CD16+ monocytes in the pathogenesis of inflammatory bowel disease. Clin Exp Immunol. 2010;161:332\u201341.","journal-title":"Clin Exp Immunol"},{"key":"591_CR34","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/j.1572-0241.2007.01714.x","volume":"103","author":"H Hanai","year":"2008","unstructured":"Hanai H, Iida T, Takeuchi K, Watanabe F, Yamada M, Kikuyama M, Maruyama Y, Iwaoka Y, Hirayama K, Nagata S, Takai K. Adsorptive depletion of elevated proinflammatory CD14\u2009+\u2009CD16\u2009+\u2009DR++ monocytes in patients with inflammatory bowel disease. Am J Gastroenterol. 2008;103:1210\u20136.","journal-title":"Am J Gastroenterol"},{"key":"591_CR35","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/ibd.20017","volume":"13","author":"T Kanai","year":"2007","unstructured":"Kanai T, Makita S, Kawamura T, Nemoto Y, Kubota D, Nagayama K. Extracorporeal elimination of TNF-alpha-producing CD14 (dull) CD16 (+) monocytes in leukocytapheresis therapy for ulcerative colitis. Inflamm Bowel Dis. 2007;13:284\u201390.","journal-title":"Inflamm Bowel Dis"},{"key":"591_CR36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-230X-14-27","volume":"14","author":"K Mera","year":"2014","unstructured":"Mera K, Uto H, Mawatari S, Ido A, Yoshimine Y, Nosaki T, Oda K, Tabu K, Kumagai K, Tamai T, Moriuchi A, Oketani M, Shimada Y, Hidaka M, Eguchi S, Tsubouchi H. Serum levels of apoptosis inhibitor of macrophage are associated with hepatic fibrosis in patients with chronic hepatitis C. BMC Gastroenterol. 2014;14:27.","journal-title":"BMC Gastroenterol"},{"key":"591_CR37","doi-asserted-by":"crossref","first-page":"e109123","DOI":"10.1371\/journal.pone.0109123","volume":"9","author":"T Yamazaki","year":"2014","unstructured":"Yamazaki T, Mori M, Arai S, Tateishi R, Abe M, Ban M, Nishijima A, Maeda M, Asano T, Kai T, Izumino K, Takahashi J, Aoyama K, Harada S, Takebayashi T, Gunji T, Ohnishi S, Seto S, Yoshida Y, Hiasa Y, Koike K, Yamamura K, Inoue K, Miyazaki T. Circulating AIM as an indicator of liver damage and hepatocellular carcinoma in humans. Plos one. 2014;9:e109123.","journal-title":"Plos one"},{"key":"591_CR38","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.celrep.2013.03.006","volume":"3","author":"S Arai","year":"2013","unstructured":"Arai S, Maehara N, Iwamura Y, Honda S, Nakashima K, Kai T, Ogishi M, Morita K, Kurokawa J, Mori M, Motoi Y, Miyake K, Matsuhashi N, Yamamura K, Ohara O, Shibuya A, Wakeland EK, Li QZ, Miyazaki T. Obesity-associated autoantibody production requires AIM to retain the immunoglobulin M immune complex on follicular dendritic cells. Cell Rep. 2013;3:1187\u201398.","journal-title":"Cell Rep"},{"key":"591_CR39","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/gut.52.4.535","volume":"52","author":"H Saito","year":"2003","unstructured":"Saito H, Fukuda Y, Katsuragi K, Tanaka M, Satomi M, Shimoyama T, Saito T, Tachikawa T. Isolation of peptides useful for differential diagnosis of Crohn\u2019s disease and ulcerative colitis. Gut. 2003;52:535\u201340.","journal-title":"Gut"},{"key":"591_CR40","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/bjs.1800790934","volume":"79","author":"AL Sheehan","year":"1992","unstructured":"Sheehan AL, Warren BF, Gear MW, Shepherd NA. Fat-wrapping in Crohn\u2019s disease: pathological basis and relevance to surgical practice. Br J Surg. 1992;79:955\u20138.","journal-title":"Br J Surg"},{"key":"591_CR41","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3389\/fimmu.2014.00462","volume":"5","author":"LI Kredel","year":"2014","unstructured":"Kredel LI, Siegmund B. Adipose-tissue and intestinal inflammation - visceral obesity and creeping fat. Front Immunol. 2014;5:462.","journal-title":"Front Immunol"},{"key":"591_CR42","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1002\/ibd.22893","volume":"18","author":"C Fink","year":"2012","unstructured":"Fink C, Karagiannides I, Bakirtzi K, Pothoulakis C. Adipose tissue and inflammatory bowel disease pathogenesis. Inflamm Bowel Dis. 2012;18:1550\u20137.","journal-title":"Inflamm Bowel Dis"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-017-0591-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T23:20:06Z","timestamp":1658791206000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-017-0591-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,11]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["591"],"URL":"https:\/\/doi.org\/10.1186\/s12876-017-0591-z","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,11]]},"article-number":"40"}}